Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Iran
Iran: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 98.0% in 2025. ▬ Flat
Latest (2025)
98.0%
Change on year
down 1.0%
World rank
16th
of 194 countries
All-time high
99.0%
in 2000
All-time low
92.0%
in 2005
Years of data
26
2000–2025
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Iran, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Iran recorded 98.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025.
That represents a change of down 1.0% on the previous year and unchanged over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Iran peaked at 99.0% in 2000 and was at its lowest, 92.0%, in 2005.
That places Iran 16th out of 194 countries with data for 2025, putting it in the top 10%.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Iran, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 99.0% | — |
| 2001 | 94.0% | -5.1% |
| 2002 | 96.0% | +2.1% |
| 2003 | 96.0% | +0.0% |
| 2004 | 99.0% | +3.1% |
| 2005 | 92.0% | -7.1% |
| 2006 | 98.0% | +6.5% |
| 2007 | 97.0% | -1.0% |
| 2008 | 96.0% | -1.0% |
| 2009 | 99.0% | +3.1% |
| 2010 | 99.0% | +0.0% |
| 2011 | 99.0% | +0.0% |
| 2012 | 97.0% | -2.0% |
| 2013 | 97.0% | +0.0% |
| 2014 | 98.0% | +1.0% |
| 2015 | 98.0% | +0.0% |
| 2016 | 98.0% | +0.0% |
| 2017 | 98.0% | +0.0% |
| 2018 | 98.0% | +0.0% |
| 2019 | 98.0% | +0.0% |
| 2020 | 98.0% | +0.0% |
| 2021 | 98.0% | +0.0% |
| 2022 | 98.0% | +0.0% |
| 2023 | 99.0% | +1.0% |
| 2024 | 99.0% | +0.0% |
| 2025 | 98.0% | -1.0% |
Iran compared with similar countries
- Iran's 98.0% is above the median for upper middle income countries, which is 85.0%, 1.2× the median. (57 countries reporting)
- Iran's 98.0% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 92.0%, 1.1× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 96.6% | 92.0% | 99.0% | 10 |
| 2010s | 98.0% | 97.0% | 99.0% | 10 |
| 2020s | 98.3% | 98.0% | 99.0% | 6 |
Countries ranked near Iran
More health data for Iran
- Un projection of annual infant deaths, annual growth rate -1.38 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5627 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,361 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,070 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.88 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0311 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.95 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Iran?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Iran was 98.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Iran?
- The highest recorded value was 99.0% in 2000.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Iran?
- The lowest recorded value was 92.0% in 2005.
- How does Iran rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Iran ranks 16th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Iran?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Iran data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).